Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New dissolvable mesh for breast reconstruction under study

NCT ID NCT06511167

First seen May 14, 2026 · Last updated Jun 19, 2026 · Updated 5 times

Summary

This study follows 135 women who had breast reconstruction after mastectomy using a special dissolvable mesh called TIGR® Matrix. Researchers want to see how the surgery affects quality of life over three years. Participants fill out questionnaires about their recovery and daily activities.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Agaplesion Markus Krankenhaus Frankfurt

    RECRUITING

    Frankfurt am Main, Hesse, 60431, Germany

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Evangelisches Krankenhaus Wesel

    RECRUITING

    Wesel, North Rhine-Westphalia, 46485, Germany

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • GRN-Klinik Weinheim

    ACTIVE_NOT_RECRUITING

    Weinheim, Baden-Wurttemberg, 69469, Germany

  • Klinik und Poliklinik für Frauenheilkunde Technische Universität München

    RECRUITING

    München, Bavaria, 80337, Germany

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Krankenhaus St. Elisabeth und St. Barbara Halle (Saale) GmbH

    RECRUITING

    Halle, 06110, Germany

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

The condition(s) this trial relates to.

breast cancer precancerous condition

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.